Free shipping on all orders over $ 500

Linoleoyl ethanolamide

Cat. No. M30475

All AbMole products are for research use only, cannot be used for human consumption.

Linoleoyl ethanolamide Structure
Synonym:

Linoleic acid monoethanolamide

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Quality Control & Documentation
Biological Activity

Linoleoyl ethanolamide (Linoleic acid monoethanolamide) is classified as a fatty acid ethanolamide. Linoleoyl ethanolamide only weakly binds G-protein-coupled cannabinoid receptors of type-1（CB1）and CB2 receptors, and inhibits the binding of [3H]CP-55,940 with Kis of 10 and 25 μM, respectively. Linoleoyl ethanolamide is 4-fold less potent than anandamide at causing catalepsy in mice and it does not prolong sleep time.

Chemical Information
Molecular Weight 323.51
Formula C20H37NO2
CAS Number 68171-52-8
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
References

[1] Isabelle Dubuc, et al. Front Immunol. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice

[2] Ailing Liu, et al. Microbiol Spectr. Adjunctive Probiotics Alleviates Asthmatic Symptoms via Modulating the Gut Microbiome and Serum Metabolome

[3] Xin-Yun Tian, et al. Front Cell Infect Microbiol. 919 Syrup Alleviates Postpartum Depression by Modulating the Structure and Metabolism of Gut Microbes and Affecting the Function of the Hippocampal GABA/Glutamate System

[4] Xiaosan Wang, et al. J Oleo Sci. Synthesis of linoleoyl ethanolamide

[5] Tsukasa Ishida, et al. Eur J Pharmacol. Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice

Related Cannabinoid Products
UCM707 

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of Anandamide.
SCH 336

SCH 336 is a potent, selective, inverse and orally active CB2 agonist.
JTE-907 

JTE-907 is a highly selective, orally active CB2 receptor inverse agonist and exerts anti-inflammatory effects in vivo.
LEI-101 

LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC50 of 8 for hCB2, and a pKi of less than 4 for hERG.
AEF0117 

AEF0117 is a signaling-specific inhibitor of the cannabinoid receptor 1 (CB1-SSi).
  Catalog
Abmole Inhibitor Catalog




Keywords: Linoleoyl ethanolamide, Linoleic acid monoethanolamide supplier, Cannabinoid, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.


 
Get to Know Us
Customer Support
Resources
Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.